% CI, 4.49 to 1.22;
P < .001) and better after HL/S than after UGFS (2.60;
95% CI, 3.99 to 1.22; P < .001). Generic QoL measures
were similar. Early results of CAC vs RFA found no difference in anatomic closure or minor AEs in patients
treated